Article

CCH procedure reduces inflammation, promotes healing

Bio-Tissue Inc. introduced a new procedure for conjunctivochalasis-the reservoir restoration procedure for conjunctivochalasis (CCH) dry eye.

Boston-Bio-Tissue Inc. introduced a new procedure for conjunctivochalasis-the reservoir restoration procedure for conjunctivochalasis (CCH) dry eye.

The procedure restores the tear reservoir and tear meniscus to their natural states using cryopreserved amniotic membrane and inhibits matrix metalloproteinases activity. While there are currently different techniques for CCH, none currently address the Tenon’s capsule, which new evidence suggests will lead to more successful and durable outcomes, according to the company.

 

This new surgical procedure offers two techniques that remove the unhealthy Tenon, one using sutures, and the other without.

“Our new [procedure] uses cryopreserved amniotic membrane to help reduce inflammation, promote regenerative healing, suppress pain, and achieve superior cosmetic results,” said Tom Daniells, chief commercial officer, Bio-Tissue. “For patients with CCH dry eye, this is extremely beneficial as it helps to speed recovery and provides a solution for those patients who don’t respond well to medical treatment.”

For more articles in this issue of Ophthalmology Times’ Conference Brief, click here.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.